Month: January 2026

Agreement Finalized and Solution Deployed in 2025; Delivering New Tax-Efficient Non-Gaming Revenue to WarHorse Gaming Properties NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — WarHorse Gaming announced today it has deployed Context Networks’ Contextual Promotions Media Network™ (CPMN™) powered by Mobiquity Technologies’ (OTCQB: MOBQ) next-generation advertising and data intelligence solutions across two WarHorse Casino properties in Nebraska. The agreement was sold through Context Networks’ established reseller, NRT Technology. The deployment brings Context Networks’ full-stack, end-to-end advertising and analytics platform into gaming environments, enabling WarHorse Gaming to operate as a digital publisher while creating incremental, tax-efficient, non-gaming revenue. Powered by Mobiquity’s advanced advertising technology,...

DURANGO, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), America’s Chocolatier™ and a leading franchiser of a premium chocolate and confectionary retail store concept, will host a conference call on Wednesday, January 14, 2026 at 9:00 a.m. Eastern time to discuss its fiscal third quarter 2026 results. The Company’s results will be reported in a press release prior to the call. The RMCF management team will host the conference call, followed by a question-and-answer period. Attendees are invited to submit questions ahead of the call by emailing the Company’s investor relations team at RMCF@elevate-ir.com. The conference call details are as follows: Date: Wednesday, January 14, 2026Time: 9:00 a.m. Eastern timeDial-in registration link: hereLive...

Initial design and prototype order valued at approximately $1.2 million Integration of OSS hardware into prime contractor system further validates OSS capabilities for next-generation 360-degree vision and sensor processing solutions ESCONDIDO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced it has received an approximately $1.2 million pre-production order from a new U.S. defense prime contractor for the design, development, and delivery of ruggedized integrated compute and visualization systems for U.S. Army combat vehicles. “This engagement with a new, top-tier U.S. defense prime contractor marks a meaningful milestone for OSS,”...

ATLANTA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. has named Kristy Santiago as the next General Manager of KFVS (CBS and CW) in Cape Girardeau, Missouri and WQWQ-LD (Telemundo) in Paducah, Kentucky.Kristy brings decades of experience in television station management and sales operations. Throughout her career, she has overseen operations for multiple networks across several markets. She was instrumental in launching a number of Telemundo, CW and FOX affiliations. Most recently, Kristy served as General Manager of KION (CBS), KMUV (Telemundo), KCBA (CW) in Monterey, CA. She also served in leadership positions in Grand Junction, CO and Palm Springs, CA. In addition to her professional accomplishments, Kristy has been active in both industry and community organizations. She has served on Boards including the California...

MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), today announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to extend the deadline for regaining compliance with the Nasdaq Listing Rules, subject to certain conditions related to the Company’s ongoing efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”). Pursuant to the Panel’s decision, the Company must demonstrate compliance with the Periodic Filing Rule on or before March 31, 2026, with respect to 2024 fiscal year audited financial results, and April 17, 2026, with respect to reporting first half 2025 financial results (the “Extension Periods”). The Company today also announced that it received a letter...

David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the appointment of David Zaccardelli, Pharm.D. to its Board of Directors as Chair of the Board and the appointment of Rita Jain, M.D., as an independent director, both effective immediately. “We are excited to welcome Dr. David Zaccardelli and Dr. Rita Jain to our Board of Directors. I, along with the rest of our Board, am confident that David and Rita will make a significant impact on SAB BIO,” said Samuel J. Reich, CEO, SAB BIO. Mr. Reich continued, “David is an esteemed...

New Strategic Partnerships with The Hockey News and Expansion of Elite Journalist Network to 150+ Former Sports Illustrated Media Professionals SAN DIEGO, CA, Jan. 07, 2026 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”) today highlighted recent developments achieved by its planned merger partner, Roundtable, including a long-term strategic partnership with The Hockey News and the onboarding of 50 additional Sports Illustrated journalists, expanding its platform to more than 150 former Sports Illustrated media professionals. The Hockey News Partnership & Board Appointment Roundtable recently executed a 10-year strategic partnership agreement with The Hockey News, a major sports media brand, encompassing all commerce, media, and platform operations with a $15 million title sponsorship commitment. Graeme...

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as of January 6, 2026 4D-150 PRISM wet AMD 2-year Phase 2b data expected mid-2026 4D-150 DME global Phase 3 trial initiation expected Q3 2026; 2-year SPECTRA Phase 1/2 data expected H2 2026 Appointed Glenn Sblendorio to Board of Directors, adding deep commercial and operating experience, including in retina therapeutics Company to present strategic outlook at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 7:30am PTEMERYVILLE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...